Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Celera, Merck Enter Onco-Research Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Celera, Merck Enter Onco-Research Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celera has entered into a research collaboration with Merck to develop biomarker and pharmacogenomic tests for cancer patients. Under the terms of the agreement, Celera will evaluate certain gene expression profiles identified by Merck with the goal of developing diagnostic predictors for use in Merck’s clinical trials, and to potentially form the basis for commercial diagnostic tests for oncology therapies.

Celera will receive an undisclosed payment for this collaboration and is eligible to receive an additional payment if Merck transfers a Celera validated gene expression assay to a clinical reference lab upon completion.

“This collaboration with Merck is a strong validation of Celera’s diagnostic expertise in targeted medicine and our development capabilities,” said Thomas White, Ph.D., chief scientific officer at Celera. “The potential outcomes from this collaboration could lead to the development of tests that may improve individualized therapy for the treatment of cancer.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics